Litigation Details for Millennium Pharmaceuticals Inc. v. Actavis LLC (D. Del. 2016)

Millennium Pharmaceuticals Inc. v. Actavis LLC (D. Del. 2016)

Docket		Date Filed	2016-04-04
Court	District Court, D. Delaware	Date Terminated	2019-08-28
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Patents	6,713,446; 6,958,319
Link to Docket	External link to docket

Details for Millennium Pharmaceuticals Inc. v. Actavis LLC (D. Del. 2016)

Date Filed	Document No.	Description	Snippet	Link To Document
2016-10-10	19		expiration of U.S. Patent Nos. 6,713,446 (“the ’446 patent”) and 6,958,319 (“the ’319 patent”); WHEREAS…infringement of the ’446 patent; asserted that the claims of the ’446 patent are invalid; and counterclaimed…infringement and invalidity of the ’446 patent and ’319 patent; WHEREAS, the expiration of the…NDA Product, before the expiration of the ’446 patent is an act of infringement of at least claims 1-…1-6, 8-10, 39-40, 42, 62, and 63 of the ’446 patent (the “Asserted Claims”) under 35 U.S.C. § 271(e)(	External link to document
2016-10-11	20		the expiration of U.S. Patent Nos. 6,713,446 (''the '446 patent") and 6,958,319 …infringement of the '446 patent; asserted that the claims of the '446 patent are invalid; and counterclaimed…infringement and invalidity of the '446 patent and '319 patent; WHEREAS, the expiration of the…6,958,319 ("the '319 patent"); WHEREAS in this action, Millennium filed a Complaint (Dkt…Product, before the expiration of the '446 patent is an act of infringement of at least claims 1-	External link to document
2016-04-04	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number: 6,713,446 B2. (klc) (Entered: …2016 28 August 2019 1:16-cv-00223 830 Patent None District Court, D. Delaware	External link to document